Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Characterizing the impact of uncertain mismatch repair-deficient results for individuals undergoing screening for Lynch syndrome
FY 2021-22
Summary
Lynch syndrome (LS) is the most common cause of inherited colorectal cancer (CRC). LS is caused by inherited changes in one of four DNA mismatch repair (MMR) genes, resulting in an increased risk for developing numerous cancers. When a patient is diagnosed with CRC, they are often screened for LS. As LS is caused by changes in MMR genes, a sample of the tumour is examined for MMR proteins. CRC without the presence of MMR proteins are considered MMR-deficient. Only some patients with MMR-deficient CRC, however, are found to have an inherited mutation in an MMR gene that is consistent with a diagnosis of LS. The remaining group have unexplained MMR deficiency and a diagnosis of LS cannot be confirmed; patients are left without a definitive diagnosis. Using a combination of surveys and qualitative interviews, I will evaluate the ability of these patients to cope with their uncertain diagnosis and what their diagnosis has meant for their family members. For each patient, I aim to evaluate their knowledge and recollection of their results, the information they received from the Genetics clinic, and how screening guidelines align with their current monitoring routines. Patients with MMR-deficient tumors are often treated as if they have LS and are subjected to rigorous, and often unnecessary, cancer screening. Patients who do not have inherited variants do not require the same level of observation, yet current practices lead to many patients being over-screened. Characterizing the impact of uncertain MMR-deficient results may encourage the implementation of additional genetic testing to clarify a diagnosis for these patients and reduce screening recommendations. Findings from this study may also impact how information is provided to individuals with other uncertain diagnoses.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466815
Name
Joynt Alyssa C
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the impact of uncertain mismatch repair-deficient results for individuals undergoing screening for Lynch syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Genetic Counselling; Hereditary Cancer; Lynch Syndrome; Surveillance Recommendations; Uncertainty
Abstract
Lynch syndrome (LS) is the most common cause of inherited colorectal cancer (CRC). LS is caused by inherited changes in one of four DNA mismatch repair (MMR) genes, resulting in an increased risk for developing numerous cancers. When a patient is diagnosed with CRC, they are often screened for LS. As LS is caused by changes in MMR genes, a sample of the tumour is examined for MMR proteins. CRC without the presence of MMR proteins are considered MMR-deficient. Only some patients with MMR-deficient CRC, however, are found to have an inherited mutation in an MMR gene that is consistent with a diagnosis of LS. The remaining group have unexplained MMR deficiency and a diagnosis of LS cannot be confirmed; patients are left without a definitive diagnosis. Using a combination of surveys and qualitative interviews, I will evaluate the ability of these patients to cope with their uncertain diagnosis and what their diagnosis has meant for their family members. For each patient, I aim to evaluate their knowledge and recollection of their results, the information they received from the Genetics clinic, and how screening guidelines align with their current monitoring routines. Patients with MMR-deficient tumors are often treated as if they have LS and are subjected to rigorous, and often unnecessary, cancer screening. Patients who do not have inherited variants do not require the same level of observation, yet current practices lead to many patients being over-screened. Characterizing the impact of uncertain MMR-deficient results may encourage the implementation of additional genetic testing to clarify a diagnosis for these patients and reduce screening recommendations. Findings from this study may also impact how information is provided to individuals with other uncertain diagnoses.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Joynt, Alyssa C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~